| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PNPBP.2010.07.037 |
| P698 | PubMed publication ID | 20708056 |
| P2093 | author name string | David Lowe | |
| Neil E Paterson | |||
| Taleen Hanania | |||
| Barbara Caldarone | |||
| Afshin Ghavami | |||
| Wenzhong Min | |||
| Adrian Hackett | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1455-1464 | |
| P577 | publication date | 2010-08-11 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats | |
| P478 | volume | 34 |
| Q35223957 | AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology |
| Q47188459 | Assessment of substance abuse liability in rodents: self-administration, drug discrimination, and locomotor sensitization |
| Q35799702 | Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile |
| Q37259110 | Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats |
| Q35079394 | Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline |
| Q52627438 | Discovery and development of varenicline for smoking cessation. |
| Q35402036 | Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depression |
| Q38732951 | Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons". |
| Q37961439 | Disentangling the nature of the nicotine stimulus. |
| Q35699233 | Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. |
| Q37351302 | Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats |
| Q37642452 | Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration |
| Q46240693 | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles |
| Q34401397 | Nicotinic receptor antagonists as treatments for nicotine abuse |
| Q91833966 | Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats |
| Q36016445 | PKCε phosphorylates α4β2 nicotinic ACh receptors and promotes recovery from desensitization |
| Q92565525 | Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development |
| Q42130425 | The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats. |
| Q41566428 | The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats |
| Q47550611 | The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption |
| Q38338790 | The role of mesoaccumbens dopamine in nicotine dependence |
| Q35761753 | Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine |
| Q90356662 | α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats |
Search more.